Role of ROS‑mediated autophagy in melanoma (Review)

• Published in: Molecular medicine reports Vol. 26; no. 4
• Main Authors: Zhang, Xuebing, Li, Huaijun, Liu, Chengxiang, Yuan, Xingxing
• Format: Journal Article
• Language: English
• Published: Athens Spandidos Publications 01.10.2022; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Analysis; Antineoplastic drugs; Antitumor agents; Autophagy; Autophagy (Cytology); Cancer therapies; Care and treatment; Cell fate; Cell growth; Chemotherapy; Cytotoxicity; Diagnosis; DNA damage; DNA repair; Drug resistance; Enzymes; Etiology; Fatty acids; Health aspects; Homeostasis; Investigations; Kinases; Melanoma; Metabolism; Metabolites; Metastasis; Oxidation; Oxidative stress; Pathogenesis; Physiology; Prevention; Proteins; Reactive oxygen species; Review; Skin cancer; Tumorigenesis; Tumors; Ultraviolet radiation; China
• ISSN: 1791-2997; 1791-3004
• DOI: 10.3892/mmr.2022.12819

Melanoma is the most aggressive form of skin cancer with the poorest prognosis and its pathogenesis has yet to be fully elucidated. As key factors that regulate cellular homeostasis, both reactive oxygen species (ROS) and autophagy are involved in the development of melanoma, from melanomagenesis to progression and drug resistance. However, the interaction between ROS and autophagy in the etiology and treatment of melanoma is not well characterized. The present review examined the production of ROS and the role of oxidative stress in melanoma, and summarized the role of ROS-mediated autophagy in melanomagenesis and melanoma cell fate decision following treatment with various anticancer drugs. The present findings may lead to a better understanding of the pathogenesis and progression of melanoma, and suggest promising treatment options for this disease.